Cargando…
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
Fibrolamellar carcinoma (FLC) of the liver is a rare type of liver cancer that is prevalent in children and young adults, often less than 40 years old. The etiology is unclear. It presents without underlying liver disease with distinctive histological features such as fibrous collagen bands surround...
Autores principales: | Gummadi, Jyotsna, Wang, Xin, Xie, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198173/ https://www.ncbi.nlm.nih.gov/pubmed/37215364 http://dx.doi.org/10.2147/JHC.S406902 |
Ejemplares similares
-
Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015) -
Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012) -
Human liver organoids for disease modeling of fibrolamellar carcinoma
por: Narayan, Nicole J.C., et al.
Publicado: (2022) -
A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects
por: Polychronidis, Georgios, et al.
Publicado: (2022) -
Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma
por: Alsina, Angel E., et al.
Publicado: (2016)